screening_skill

This skill manages gynecologic cancer screening workflows, records HPV, TCT, co-testing, and tumor markers, and provides risk-based guidance.
  • Python

2.5k

GitHub Stars

4

Bundled Files

2 months ago

Catalog Refreshed

4 months ago

First Indexed

Readme & install

Copy the install command, review bundled files from the catalogue, and read any extended description pulled from the listing source.

Installation

Preview and clipboard use veilstrat where the catalogue uses aiagentskills.

npx veilstrat add skill openclaw/skills --skill screening

  • examples.md4.3 KB
  • schema.json6.3 KB
  • schema.md3.4 KB
  • SKILL.md4.6 KB

Overview

This skill manages gynecological cancer screening workflows and longitudinal tracking for HPV testing, TCT (Pap smear), co-testing, and tumor marker monitoring. It organizes results, performs risk stratification, recommends next steps, and stores structured screening records for follow-up and reporting.

How this skill works

The skill parses user input to identify the operation type (hpv, tct, co-testing, marker, status, next) and normalizes test results into standard categories and risk levels. It applies guideline-based risk rules for HPV types and Bethesda TCT categories, generates management recommendations (for example colposcopy or interval re-screening), and produces structured JSON records for persistence and trend analysis.

When to use it

  • Record a new HPV, TCT, co-test, or tumor marker result for a patient.
  • Assess combined HPV+TCT results to determine immediate action or surveillance interval.
  • Monitor tumor marker trends (CA125, CA19-9, CEA, AFP) for ovarian or endometrial cancer follow-up.
  • Generate a patient screening status or next screening reminder.
  • Manage higher-frequency screening for high-risk groups (HIV, immunosuppression, prior cervical cancer).

Best practices

  • Provide clear input with test type, date, numeric marker values, and HPV types when available.
  • Follow age-based screening strategies: 21–29 TCT every 3 years, 30–65 co-testing every 5 years or TCT every 3 years.
  • Treat HPV 16/18 positive results as high priority and recommend prompt colposcopy evaluation.
  • Use repeated marker measurements to establish trends rather than relying on single values.
  • Document follow-up actions and dates to maintain an auditable screening history.

Example use cases

  • Log an HPV PCR result specifying positive/negative and HPV genotype(s) to trigger risk assessment and next-step recommendation.
  • Enter a TCT (Bethesda) result such as NILM, ASC-US, LSIL, or HSIL to generate management guidance.
  • Record CA125 values over time to classify as normal/elevated and display trend stability or rise.
  • Submit a combined co-testing result to get an integrated risk level and suggested interval or urgent referral.
  • Query a patient’s screening status to receive a JSON summary of last tests and days until next recommended screen.

FAQ

It maps types into high-risk (16/18 as highest, others like 31/33/52/58 as high) or low-risk groups and assigns management accordingly.

What actions follow HSIL or HPV 16/18 positivity?

Both typically prompt immediate colposcopy and biopsy because they indicate high risk for CIN2+ or invasive disease.

Built by
VeilStrat
AI signals for GTM teams
© 2026 VeilStrat. All rights reserved.All systems operational